- Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor‐κB/MDR1 pathway in colorectal cancer
Yueping Zhan et al, 2020, Cancer Science CrossRef - Repurposing cardiac glycosides for anticancer treatment: a review of clinical studies
Wan Najbah Nik Nabil et al, 2024, Drug Discovery Today CrossRef - Advances in the treatment of pancreatic cancer with traditional Chinese medicine
Yanhua Zhang et al, 2023, Frontiers in Pharmacology CrossRef - Bufalin Induces Apoptosis and Improves the Sensitivity of Human Glioma Stem-Like Cells to Temozolamide
Jia Liu et al, 2019, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef - Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment
Li-Juan Deng et al, 2020, European Journal of Pharmacology CrossRef - Super Para-Magnetic Iron Oxide Nanoparticles (SPIONs) in the Treatment of Cancer: Challenges, Approaches, and its Pivotal Role in Pancreatic, Colon, and Prostate Cancer
Sameea Ahmed Khan et al, 2023, Current Drug Delivery CrossRef - Bufalin serves as a pharmaceutic that mitigates drug resistance
Linxuan Miao et al, 2023, Drug Metabolism Reviews CrossRef - Molecular mechanisms underlying the�antimetastatic activity of bufalin (Review)
Jie Wang et al, 2018, Molecular and Clinical Oncology CrossRef - Bufalin Suppresses Colorectal Cancer Cells by the Blockade of Canonical Wnt Signaling Pathway
Wanmi Sui et al, 2022, 2022 4th International Conference on Intelligent Medicine and Image Processing CrossRef - Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer
Sheema Khan et al, 2019, Biomaterials CrossRef - New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin
Chien-shan Cheng et al, 2019, Cancer Cell International CrossRef - The inhibition of heme oxygenase-1 enhances the chemosensitivity and suppresses the proliferation of pancreatic cancer cells through the SHH signaling pathway
Liang Han et al, 2018, International Journal of Oncology CrossRef - Induction of Apoptosis in Human Pancreatic Cancer Stem Cells by the Endoplasmic Reticulum-Targeted Alkylphospholipid Analog Edelfosine and Potentiation by Autophagy Inhibition
Consuelo Gajate et al, 2021, Cancers CrossRef - Bufalin for an innovative therapeutic approach against cancer
Laura Soumoy et al, 2022, Pharmacological Research CrossRef - Reactive oxygen species-inducing titanium peroxide nanoparticles as promising radiosensitizers for eliminating pancreatic cancer stem cells
Mohammed Salah et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef - Traditional Chinese medicine may be further explored as candidate drugs for pancreatic cancer: A review
Yue Gao et al, 2021, Phytotherapy Research CrossRef - Breast Cancer Stem Cell Therapeutics, Multiple Strategies Versus Using Engineered Mesenchymal Stem Cells With Notch Inhibitory Properties: Possibilities and Perspectives
Bipasha Bose et al, 2018, Journal of Cellular Biochemistry CrossRef - Bufalin inhibits gastric cancer invasion and metastasis by down-regulating Wnt/ASCL2 expression
Jie Wang et al, 2018, Oncotarget CrossRef - An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives
Qingmei Ye et al, 2023, Frontiers in Pharmacology CrossRef - Jiedu Xiaozheng Yin extract targets cancer stem cells by Wnt signaling pathway in colorectal cancer
Hailan Feng et al, 2025, Journal of Ethnopharmacology CrossRef - Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells
Jian Sun et al, 2017, Oncology Reports CrossRef - Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism
J. Wei et al, 2022, Clinical and Translational Oncology CrossRef